Several sessions have been presented at the 2020 American Society of Hematology’s Annual Meeting, highlighting research data and findings specifically related to myeloma novel targeting agents. There were 2 terms, off-the-shelf and Allogeneic CAR, referred to many times yesterday during immunotherapy sessions. While I felt I understand the context of the discussions, I was immediately […]